Abstract:Mutations in the Aminoadipate-Semialdehyde Synthase ( AASS ) gene encoding α-aminoadipic semialdehyde synthase lead to hyperlysinemia-I, a benign metabolic variant without clinical significance, and hyperlysinemia-II with developmental delay and intellectual disability. Although both forms of hyperlysinemia display biochemical phenotypes of questionable clinical significance, an association between neurologic disorder and a pronounced biochemical abnormality remains a challenging clinical question. Here, we report that Aass mutant male and female mice carrying the R65Q mutation in α-ketoglutarate reductase (LKR) domain have an elevated cerebral lysine level and a normal brain development, whereas the Aass mutant mice carrying the G489E mutation in saccharopine dehydrogenase (SDH) domain exhibit elevations of both cerebral lysine and saccharopine levels and a smaller brain with defective neuronal development. Mechanistically, the accumulated saccharopine, but not lysine, leads to impaired neuronal development by inhibiting the neurotrophic effect of glucose-6-phosphate isomerase (GPI). While extracellular supplementation of GPI restores defective neuronal development caused by G498E mutation in SDH of Aass. Altogether, our findings not only unravel the requirement for saccharopine degradation in neuronal development, but also provide the mechanistic insights for understanding the neurometabolic disorder of hyperlysinemia-II. SIGNIFICANCE STATEMENT The association between neurologic disorder and a pronounced biochemical abnormality in hyperlysinemia remains a challenging clinical question. Here, we report that mice carrying the R65Q mutation in lysine α-ketoglutarate reductase (LKR) domain of aminoadipate-semialdehyde synthase (AASS) have an elevated cerebral lysine levels and a normal brain development, whereas those carrying the G489E mutation in saccharopine dehydrogenase (SDH) domain of AASS exhibit an elevation of both cerebral lysine and saccharopine and a small brain with defective neuronal development. Furthermore, saccharopine impairs neuronal development by inhibiting the neurotrophic effect of glucose-6-phosphate isomerase (GPI). These findings demonstrate saccharopine degradation is essential for neuronal development.

Serine chirality guides metabolic flow between one-carbon metabolism and neuromodulator synthesis

Methyl-Metabolite Depletion Elicits Coordinated Responses to Support Heterochromatin Stability and Epigenetic Persistence

A comprehensive review on signaling attributes of serine and serine metabolism in health and disease

Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation

Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism

Advances and challenges in serine in the central nervous system: physicochemistry, physiology, and pharmacology

Sources and Sinks of Serine in Nutrition, Health, and Disease

Serine and one-carbon metabolism in cancer

Dihydrofolate reductase activity controls neurogenic transitions in the developing neocortex

Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies

In vitro evidence that D-serine disturbs the citric acid cycle through inhibition of citrate synthase activity in rat cerebral cortex

Regional contributions of D-serine to Alzheimer's disease pathology in male AppNL–G–F/NL–G–F mice

A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes

Control of epigenomic landscape and development of fetal male germ cells through L-serine metabolism

Serine racemase expression profile in the prefrontal cortex and hippocampal subregions during aging in male and female rats

Purinosomes and Purine Metabolism in Mammalian Neural Development: A Review

Unique tau- and synuclein-dependent metabolic reprogramming in neurons distinct from normal aging

Serine Racemase mediates subventricular zone neurogenesis via fatty acid metabolism

The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase

Serine Supports IL-1β Production in Macrophages Through mTOR Signaling

The Development of a Regulator of Human Serine Racemase for N-Methyl-D-aspartate Function